Grizzly Bulls
Following Immuneering Corp?

Immuneering Corp

Financial performance and company analysis from public filings and market data.
IMRXNasdaq
Class A common Stock, par value $0.001 per share
Latest close
$3.595
Oct 16, 2026 · completed session
Compare companies

Company snapshot

A consistent view of the latest supported company value and reported operating results.

Market cap
Unknown
Revenue (TTM)
Unknown
Net income (TTM)
-$57.3M
Through Jun 30, 2026
Free cash flow (TTM)
-$57.0M
Through Jun 30, 2026

Fundamental lens

Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.

Profitability
Loss-making
Is trailing-twelve-month net income positive?

Trailing-twelve-month net income is negative. As of 2026-06-30.

Net income (TTM): -$57.3M
Cash generation
Negative free cash flow
Is trailing-twelve-month free cash flow positive?

Trailing-twelve-month operating cash flow less capital expenditures is negative. As of 2026-06-30.

Free cash flow (TTM): -$57M
Liquidity
Current assets above liabilities
Do reported current assets cover reported current liabilities?

Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-30.

Current assets: $158M · Current liabilities: $8.1M
Recent operating direction
Unknown
What changed in the latest comparable reported results?

Comparable retained change history is not available through this reader.

How this lens works

Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.

Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.

Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.

Descriptive decision support only. No composite score, hidden weighting, cross-company rank, or investment recommendation is produced.

Market summary

Completed-session reference prices from IEX for Oct 16, 2026.

Open
$3.60
Completed session
High
$3.675
Completed session
Low
$3.575
Completed session
Close
$3.595
Completed session

Price statistics

1M close return
-19.4%
Through Oct 16, 2026
3M close return
-24.6%
Through Oct 16, 2026
50-session reference-close average
$4.527
Through Oct 16, 2026

IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Price history

Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.

Immuneering Corp recent price history254 observations from Oct 13, 2025 to Oct 16, 2026. Values range from $3.43 to $8.32.$8.71$7.29$5.87$4.46$3.04Oct 13Jan 13Apr 16Jul 20Oct 16Close ($ per share)Session date
Historical reference closes · Oct 12, 2025–Oct 16, 2026 · 254 observations · per share · Source: IEX
IEX Historical Data Terms

Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.

About this market data

IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.

Listing & sources

Ticker: IMRX · Exchange: Nasdaq · Class A common Stock, par value $0.001 per share

SEC issuer CIK: 0001790340

Listing source refreshed: 2026-09-13

SEC listing source ↗